513
Views
1
CrossRef citations to date
0
Altmetric
Original Research Articles

Prevalence of abnormal findings when adopting new national and international Global Lung Function Initiative reference values for spirometry in the Finnish general population

, &
Article: 30658 | Received 07 Dec 2015, Accepted 01 Jul 2016, Published online: 06 Sep 2016

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. 2015. Available from: http://www.goldcopd.org/ [cited 30 May 2016]..
  • Global Initiative for Asthma (GINA). From the Global Strategy for Asthma Management and Prevention. 2014. Available from: http://www.ginasthma.org/ [cited 30 May 2016]..
  • Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, etal. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008; 63: 1046–51.
  • Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, etal. ERS Task Force. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012; 40: 1324–43.
  • Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H, etal. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med. 2008; 177: 253–60.
  • Ben Saad H, El Attar MN, Mabrouk KH, Abdelaziz AB, Abdelghani A, Bousarssar M, etal. The recent multi-ethnic global lung initiative 2012 (GLI 2012) reference values don't reflect contemporary adult's North African spirometry. Respir Med. 2013; 107: 2000–8.
  • Sluga R, Smeele IJM, Lucas AE, Thoonen BP, Grootens-Sekelenburg JG, Heijdra YF, etal. Impact of switching to new spirometric reference equations on severity staging of airflow obstruction in COPD: a cross-sectional observational study in primary care. Prim Care Respir J. 2014; 23: 85–91.
  • Backman H, Lindberg A, Sovijärvi A, Larsson K, Lundbäck B, Rönmark E. Evaluation of the global lung function initiative 2012 reference values for spirometry in a Swedish population sample. BMC Pulm Med. 2015; 15: 26.
  • Brazzalle DJ, Hall GL, Pretto JJ. Effect of adopting the new global lung function initiative 2012 reference equations on the interpretation of spirometry. Respiration. 2013; 86: 183–9.
  • Quanjer PH, Brazzale DJ, Boros PW, Pretto JJ. Implications of adopting the Global Lungs Initiative 012 all-age reference equations for spirometry. Eur Respir J. 2013; 42: 1046–54.
  • Piirilä P, Pietinalho A, Loponen M, Naumanen H, Nurminen M, Siukola A, etal. The quality of spirometric examinations in Finland: results from a national questionnaire survey. Clin Physiol Funct Imaging. 2002; 22: 233–9.
  • Viljanen AA, Halttunen PK, Kreus K-E, Viljanen BC. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest. 1982; 42(Suppl. 159): 5–20.
  • Koillinen H, Wanne O, Niemi V, Laakkonen E. Terveiden suomalaislasten spirometrian ja uloshengityksen huippuvirtauksen viitearvot. Suomen Lääkärilehti. 1998; 39: 395–402. in Finnish.
  • Kainu A, Timonen KL, Toikka J, Qaiser B, Pitkäniemi J, Kotaniemi JT, etal. Reference values of spirometry for Finnish adults. Clin Physiol Funct Imaging. 2015. doi: http://dx.doi.org/10.1111/cpf.12237 [Epub ahead of print]..
  • Pereira CAC, Duarte AA, Gimenez Z, Soares MR. Comparison between reference values for FVC, FEV1, and FEV1/FVC ratio in White adults in Brazil and those suggested by the Global Lung Function Initiative 2012. J Bras Pneumol. 2014; 40: 397–402.
  • Kubota M, Kobayashi H, Quanjer PH, Omori H, Tatsumi K, Kanazawa M, etal. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014; 52: 242–50.
  • Quanjer PH, Kubota M, Kobayashi H, Omori H, Tatsumi K, Kanazawa M, etal. Secular changes in relative leg length confound height-based spirometric reference values. Chest. 2014; 147: 792–7.
  • Kotaniemi J-T, Sovijärvi A, Lundbäck B. Chronic obstructive pulmonary disease in Finland: prevalence and risk factors. COPD. 2005; 3: 331–9.
  • Kainu A, Lindqvist A, Sarna S, Lundbäck B, Sovijärvi A. FEV1 response to bronchodilation in an adult urban population and in healthy adults. Chest. 2008; 134: 387–93.
  • American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995; 152: 1107–36.
  • Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, etal. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26: 948–68.
  • Halttunen P, Sovijärvi ARA. Use of reference values of lung function studies in the assessment of results. Suom Lääk l. 1984; 39: 2119–24. in Finnish.
  • Quanjer PH, Pretto JJ, Drazzale DJ, Boros PW. Grading the severity of airways obstruction: new wine in new bottles. Eur Respir J. 2014; 43: 505–12.
  • Quanjer PH, Stocks J, Cole TJ, Hall GL, Stanojevic S, on behalf of the Global Lungs Initiative . Influence of secular trends and sample size on reference equations for lung function tests. Eur Respir J. 2011; 37: 658–64.
  • Altman DG. Practical statistics for medical research. 1991; London: Chapman&Hill.
  • Kotaniemi JT, Hassi J, Kataja M, Jönsson E, Laitinen LA, Sovijärvi AR, etal. Does non-responder bias have a significant effect on the results in a postal questionnaire study?. Eur J Epidemiol. 2001; 17: 809–17.
  • Kanervisto M, Vasankari T, Laitinen T, Heliövaara M, Jousilahti P, Saarelainen S. Low socioeconomic status is associated with chronic obstructive airway diseases. Respir Med. 2011; 105: 1140–6.